HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of an increase of the hematocrit on middle cerebral artery peak and umbilical vein maximum velocities in anemic fetuses.

AbstractOBJECTIVE:
To measure the effects of acute large increases of the hematocrit on fetal peak arterial and maximum venous blood flow velocities.
METHODS:
Middle cerebral artery peak flow velocities and umbilical vein maximum flow velocities were measured before, immediately after, and 12-24 h after intrauterine transfusions. All measurements were standardized for gestational age.
RESULTS:
Complete measurements were obtained at 60 intrauterine transfusions. The mean hematocrit before intrauterine transfusion was 0.19 l/l and after 0.40 l/l. The middle cerebral artery peak flow velocity decreased immediately after transfusion in 59 of the 60 cases. There was a rise in umbilical vein maximum flow velocity immediately after intrauterine transfusion in 37 of the 60 cases. The sensitivity of middle cerebral artery peak flow velocity for severe anemia before intrauterine transfusion was 54% and the specificity 57%. The sensitivity of umbilical vein maximum flow velocity for severe anemia before intrauterine transfusion was 67% and the specificity 57%.
CONCLUSIONS:
An acute large increase of the fetal hematocrit significantly decreases middle cerebral artery peak flow velocity. The effect on umbilical vein maximum velocity is, however, unpredictable.
AuthorsEsther Sikkel, Frank P H A Vandenbussche, Dick Oepkes, Frans J C M Klumper, Katinka A K Teunissen, Robertjan H Meerman, Saskia Le Cessie, Humphrey H H Kanhai
JournalFetal diagnosis and therapy (Fetal Diagn Ther) 2003 Nov-Dec Vol. 18 Issue 6 Pg. 472-8 ISSN: 1015-3837 [Print] Switzerland
PMID14564123 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright 2003 S. Karger AG, Basel
Topics
  • Analysis of Variance
  • Anemia (blood, physiopathology, therapy)
  • Blood Flow Velocity (physiology)
  • Blood Transfusion, Intrauterine (methods)
  • Female
  • Fetal Diseases (physiopathology, therapy)
  • Hematocrit (methods)
  • Humans
  • Middle Cerebral Artery (physiology)
  • Pregnancy
  • Ultrasonography, Doppler (methods)
  • Umbilical Veins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: